MD Anderson receives $9M from F. W. Bert and Mae Dean Wheeler Foundation

Roy Herbst named director at Dartmouth Cancer Center

Roy S. Herbst was named director of Dartmouth Cancer Center.

March 27, 2026

Lisa Roth named director of pediatric hematology-oncology at Hassenfeld Children’s Hospital at NYU Langone

Lisa G. Roth was named director of the Division of Pediatric Hematology-Oncology at Hassenfeld Children’s Hospital at NYU Langone and Perlmutter Cancer Center. Roth is a pediatric oncologist, physician-scientist, and lymphoma survivor.

March 27, 2026

Vol.52 No.12

In Brief

Monica Baskin named interim director of VCU Massey Comprehensive Cancer Center

Monica L. Baskin was named interim director of the Virginia Commonwealth University Massey Comprehensive Cancer Center.

March 27, 2026

Vol.52 No.12

In Brief

Alice Lin Pomponio named SVP of corporate development and strategic partnerships at PICI

Alice Lin Pomponio was named senior vice president of corporate development and strategic partnerships at the Parker Institute for Cancer Immunotherapy.

March 27, 2026

Vol.52 No.12

Clinical Roundup

Combination treatment benefits patients with leptomeningeal metastases from breast cancer, MD Anderson study finds

Patients with leptomeningeal metastasis have historically had few treatment options. Now, researchers from The University of Texas MD Anderson Cancer Center have found a combination of targeted therapies, tucatinib and trastuzumab, plus the chemotherapy drug, capecitabine, may improve symptoms and extend survival in some breast cancer patients with LM.

March 27, 2026

Vol.52 No.12

Clinical Roundup

Dual-targeting approach improves immunotherapy response in glioblastoma, MD Anderson study finds

Researchers from The University of Texas MD Anderson Cancer Center have found that simultaneously blocking two key “don’t eat me” signals found in cancer cells heightens the immune response and sensitizes tumors to immunotherapy in models of glioblastoma, highlighting a promising strategy.

March 27, 2026

Vol.52 No.12

MD Anderson receives $9M from F. W. Bert and Mae Dean Wheeler Foundation

YOU MAY BE INTERESTED IN

Roy Herbst named director at Dartmouth Cancer Center

Lisa Roth named director of pediatric hematology-oncology at Hassenfeld Children’s Hospital at NYU Langone

Monica Baskin named interim director of VCU Massey Comprehensive Cancer Center

Alice Lin Pomponio named SVP of corporate development and strategic partnerships at PICI

Combination treatment benefits patients with leptomeningeal metastases from breast cancer, MD Anderson study finds

Dual-targeting approach improves immunotherapy response in glioblastoma, MD Anderson study finds

Renew today!

Subscriber content

Never miss an issue!

Login